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Abstract
Background and Objective : Chronic inflammation is the hall-
mark of the pathogenesis of H. pylori-induced gastric cancer. IL-
17A and IL-17F are inflammatory cytokines expressed by a novel 
subset of CD4+Th cells and play critical function in inflammation. 
We evaluated the relationship between IL-17A G197A, IL-17F 
A7488G and IL23R+2199 A/C polymorphisms with IL-6, IL-17, 
IL-21, IL-23 and TGF-β1 mRNAs expression in regard to H. pylori 
infection with chronic gastritis.
Materials and Methods : Total RNA and genomic DNA were ex-
tracted from gastric biopsies of 58 H. pylori-infected patient with 
gastritis. Afterward, mucosal IL-6, IL-17, IL-21, IL-23 and TGF-β1 
mRNAs expression and polymorphisms in IL-17A G197A, IL-17F 
A7488G and IL-23R +2199A/Cin gastric biopsies were determined 
by real-time PCR and PCR-RFLP.
Results : Our results show that IL-17A G197A, IL-17F A7488G 
andIL23R +2199A/C polymorphisms have no effect on mucosal 
 expression of IL-6, IL-17, IL-21 and TGF-β1 mRNAs expression in 
H. pylori-infected patients with chronic gastritis.
Conclusion : These results suggest that IL-17A G197A, IL-17F 
A7488G and IL23R +2199A/C polymorphisms no alter mucosal cy-
tokine pattern in Iranian patients with H. pylori-associated gastritis 
diseases. (Acta gastro enterol. belg., 2015, 78, 212-218).
Keywords : H. pylori, polymorphism, chronic gastritis.
Introduction 
Helicobacter pylori (H. pylori) infection is associated 
with gastritis (1) and considerable infiltration (2) of neu-
trophils, monocytes, dendritic cell, lymphocytes, and 
plasma cells into the gastric mucosa that contribute to 
maintain and expand the local inflammation (3-5). The 
risk of different clinical expression of H. pylori infection 
is thought to rely on interactions between the host  genetic 
factors and bacterial factors (6). For instance, polymor-
phisms of pro-inflammatory cytokine genes such as IL-8, 
IL-10, IL-17A, IL-1β and TNF-α that enhance inflamma-
tory response of gastric mucosa, have been correlated to 
an increased risk of gastric cancer and peptic ulcer (7,8). 
It has been shown that the mucosal levels of several 
 cytokines are significantly higher in H. pylori infected 
patient with virulence factors groups in comparison to 
patients without virulence factors groups (9,10). 
 Although H. pylori activates various mechanisms of the 
immune system, the inflammatory response is not enough 
in the majority of patients to eradicate the bacterium 
from the gastric mucosa. T helper 17 cells (Th17) are a 
new subset of T helper cells producing IL-17 (11,12). 
Recent studies revealed a new inflammation pathway of 
‘‘IL-23→IL-23R→STAT3→Th17→IL-17A/IL-17F’’ 
axis (IL-23/IL-17 axis) was proved to play pivotal role in 
inflammatory and autoimmune diseases (13), such as 
psoriasis, lupus nephritis and intestinal inflammation (14-
16). In this inflammation pathway, IL-23, the cytokine 
that is responsible for the expansion of Th17, is com-
prised by heterodimer of p40/p19 in which p40 is the 
common subunit shared with IL-12 and p19 is the spe-
cific subunit with higher affinity to IL-23R (17). IL-23R, 
as the key component to IL-23 receptor, was proved to 
play a significant role in the initiating, maintaining and 
accelerating of this IL-23/IL-17 inflammatory signal 
transduction pathway (18). In 2006, Duerr et al. found a 
strong association between Crohn’sdisease and polymor-
phisms of the IL23R gene (19). Since then, IL23Rgene 
was proved to be the predisposing gene to many other 
autoimmune/inflammatory diseases. Among the identi-
fied polymorphisms of IL23R, the functional SNP of 
+2199A/C (rs10889677) located in the 3-untranslated 
region (UTR) was repeatedly proved to be associated 
with diverse autoimmune/inflammatory diseases. How-
ever, the results are in controversial in different groups 
with different diseases (19-22). Moreover IL-17F was 
discovered to share strongest homology to IL-17A. alike 
to IL-17A, IL-17F was reported to induce the expression 
in a wide variety of chemokines, cytokines and adhesion 
molecules by human airway epithelial cells, fibroblasts 
and vein endothelial cells (23) but IL-17F had signifi-
cantly weaker activity than IL-17A (24, 25). Several 
studies have found excess expressing of IL-17A in 
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Genotyping for IL-17A G197A, IL-17F A7488G and 
IL23R +2199A/C polymorphisms
Genotyping analysis IL-17A, IL-17F and IL23R ge-
notyping were performed by polymerase chain reaction 
restriction fragment length polymorphism (PCR-RFLP) 
as reported by Wu et al. and Chen B et al. (33,34). The 
PCR amplification was performed in a total volume of 25 
µL mixture containing : 100-ng genomic DNA, 1.0 µM 
of each primer, 200 µM of each dNTP, 2.0 mM of MgCl2 
and 1.0 U Taq DNA polymerase and 10X Taq buffer 
(Fermentas) using the BiometraTgradient 96 (Biometra, 
Germany). PCR conditions were as follows : denatur-
ation at 96°C for 5 min, followed by 33 cycles of 95°C 
for 60 s, 65°C for 60 s, and 72°C for 50 s. A final exten-
sion was carried out at 72°C for 7 min for IL-17A ; dena-
turation at 95°C for 6 min, followed by 33 cycles of 95°C 
for 60 s, 65°C for 55 s, and 72°C for 60 s. A final exten-
sion was carried out at 72°C for 6 min for IL-17F ; dena-
turation at 95°C for 5 min, followed by 38 cycles of 95°C 
for 30 s, 60°C for 45 s, and 72°C for 60 s. A final exten-
sion was carried out at 72°C for 10 min for IL23R then 
Products cooling down to 4°C. The PCR products were 
digested by restriction endonuclease XagI (Fermentas) 
for IL-17A G197A, NlaIII (Fermentas) for IL-17F 
A7488G and MnLI (Fermentas) for IL23R +2199A/C 
according to the manufacturer’s instructions, at 37°C 
overnight and then separated by 10% polyacrylamide gel 
electrophoresis. Gel analysis was performed after stain-
ing with ethidium bromide. PCR products were shown to 
 various tumor tissues, including colorectal cancer, pros-
tate cancer, breast cancer and gastric cancer (26,27). 
Moreover, increasing evidences suggested the role of 
 IL-17A in H. pylori-related gastric diseases (28,29). 
Poly morphisms of IL-17A G197A (rs2275913) and IL-
17FA7488G (p.His161Arg rs763780) have recently been 
identified to be associated with the susceptibility to ulcer-
ative colitis and, rheumatoid arthritis respectively (30, 31). 
Genetic variations in inflammation-related genes, partic-
ularly cytokines and their receptors are thought to play a 
role in the outcome of infection and development of gas-
tritis. Considering that chronic gastritis and genetic pre-
disposition are important parts of a complex interaction to 
initiate gastric carcinogenesis, and these polymorphisms 
has been associated with gastric cancer without role of H. 
pylori in these patients. As a result, our study suggests 
that these polymorphisms may alter mucosal cytokine 
pattern by regulating IL-6, IL-21, IL-23, IL-17 and TGF- 
β1 production and, probably, the consequent release of 
these cytokines, the  development of severe histological 
changes in the gastric mucosa patients with gastritis.
Subjects and methods
A total of 58 H. pylori-infected gastritis patients 23 
men (43.43 ± 16.93) and 35 women (40.57 ± 14.47) with 
gastritis who were undergoing upper gastrointestinal 
 endoscopy were tested for H. pylori infection. H. pylori 
infected patients were determined by the RUT, PCR 
(16srRNA, glmM) and histological examination of 
 biopsies taken from the corpus. Patients were classified 
as H. pylori-infected only if the three tests were positive. 
Demographic and clinical data were obtained through 
 interview using a standard clinical pro forma. Exclusion 
criteria included history of gastric neoplasm or surgery, 
liver disease, and previous treatment with non-steroidal 
anti-inflammatory drugs (NSAIDs), proton pump inhibi-
tors, antibiotics, or bismuth salts. Informed consents for 
participation were signed by all the study subjects. The 
study was approved by the human research ethics com-
mittee and informed consent was obtained from each vol-
unteer before participation.
Histological examination
Gastric biopsy specimens were embedded in 10 % 
buffered formalin and stained with Hematoxylin and Eo-
sin (H&E) to examine gastritis and with giemsa to detect 
H. pylori. The histological detection of gastritis was 
blindly performed according to the Updated Sydney Sys-
tem (32).
DNA isolation
Genomic DNA was extracted from biopsies taken from 
the corpus using Biospin Tissue Genomic DNA Extrac-
tion Kit (Bio Flux, Japan). All extracted DNA was resus-
pended in UltraPureRNAse/DNAse-Free Distilled water. 
Fig. 1. — PCR-RFLP polyacrylamide gel electrophoresis of 
the IL-17A G197A and IL-17F A7488G and IL23R +2199A/C 
(rs10889677) polymorphins indicating : (A) IL-17A G197A, 
No. 1, 2, 5, 9 (AA = 102 bp) 4, 7, 8 (AC = 102, 68, 34 bp) 3, 6 
(GG = 68, 34 bp) genotypes and (B) IL-17F A7488G, No. 2, 4, 
6 (AA = 80, 63 bp) 3, 7 (GA = 143, 80, 63 bp) 1, 5 (GG = 143 
bp) genotypes and (C) IL23R +21199A/C (re10889677), No 1 
(CC = 154, 61 bp), 2, 3, 4, 5 (AC = 215, 154, 61 Bp), 6, 7 (AA 
= 215 bp) genotypes.
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Statistical analysis
Data were analyzed using SPSS 16.0 (SPSS Inc, 
 Chicago, IL). Cytokine expression is presented as means 
and differences between infected patients were analyzed 
using the Mann-Whitney test and for comparison of more 
than two groups Kruskal-Wallis tests were used. P- values 
of less than 0.05 were considered significant.
Results
Expression of IL-6, IL-21, IL-23, IL-17A and TGF-β1 
in biopsies of H. pylori-infected with SNPs in IL-17A 
G197A gene 
IL-6, IL-21, IL-23, IL-17A and TGF-β1 mRNAs were 
detectable in all biopsies was taken from H. pylori-infect-
ed. Since polymorphisms in IL-17 may affect its func-
tion, we studied the expression of inflammation-related 
cytokines in the gastric mucosa of 17 patients with poly-
morphisms IL-17A A/G, 4 patients with A/A and 21 pa-
tients with G/G (wild type). As shown in Fig. 2, the ex-
pression of IL-6 (p = 0.726), IL-17 (p = 0.842), IL-21 
(p = 0.734), IL-23 (p = 0.994) and TGF-β1 (p = 0.732) 
were not significant higher in patients with SNPs in IL-
17A gene.
Expression of IL-6, IL-21, IL-23, IL-17 and TGF-β1 
in biopsies of H. pylori-infected with SNPs in IL-17F 
A7488G gene 
IL-6, IL-21, IL-23, IL-17 and TGF-β1mRNAs were 
detectable in all biopsies was taken from H. pylori- 
be digested into three types of fragments (Fig. 1). To con-
firm the genotyping results, selected PCR samples in 
both groups including samples of each genotype were re-
genotyped by other laboratory personnel. No significant 
difference was found after genotyping the randomly se-
lected samples.
Quantitative analysis for IL-6, IL-17, IL-21, IL-23 and 
TGF-β1 in the gastric mucosa using real-time PCR
In the current study we selected biopsies from all 58 
H. pylori-infected biopsies with either G197A, A7488G 
and +2199A/C polymorphisms in IL-17A, IL-17F and 
IL23R matched by sex, age and pathology. Total RNA 
was isolated from whole gastric biopsy specimens using 
total RNA extraction biozol (bioflux, Japan). An aliquot 
containing 0.2 μg of total RNA was used for the reverse 
transcription reaction, which was conducted using the su-
perscript first-strand cDNA synthesis system (Fermentas, 
Finland) according to the manufacturer’s instructions. 
The sequences of oligonucleotide primer and probe are 
shown in Table 1. The quantification of mRNA levels 
was performed using a Rotor-Gene 3000 (Corbett). Real-
time-PCR reactions were performed in a total volume of 
25 μl containing 3 μl of synthesized cDNA solution, 
12.5 μl of 2x Rotor-Gene Probe PCR Master Mix (Qia-
gen, Germany), 500 nM of each primer and 250 nM of 
the TaqMan probe. Amplification program included a pre 
warming step (10 min at 94ºC), denaturation step (94°C 
for 15 s) and an annealing/extension step (60 °C for 60 s). 
Relative quantification of cytokine to β-actin (cytokine 
mRNA/β-actin mRNA)was determined using the 2 -ΔCт 
method (35).
Table 1. — Primer and probe sequences employed in this study
Gene Primer and probe sequence
β-actin Forward 5-AGCCTCGCCTTTGCCGA-3
Reverse 5-CTGGTGCCTGGGGCG-3
Probe FAM-CCGCCGCCCGTCCACACCCGCC-TAMRA
TGF-β1 Forward 5-CAGCAACAATTCCTGGCGATA-3
Reverse 5-AAGGCGAAAGCCCTCAATTT-3
Probe FAM-CTGCTGGCACCCAGCGACTCG-TAMRA
IL-6 Forward 5-GGTACATCCTCGACGGCATCT-3
Reverse 5-GTGCCTCTTTGCTGCTTTCAC-3
Probe FAM-TGTTACTCTTGTTACATGTCTCCTTTCTCAGGGCT-TAMRA
IL-17 Forward 5-AATCTCCACCGCAATGAGGA-3
Reverse 5-ACGTTCCCATCAGCGTTGA-3
Probe FAM-CGGCACTTTGCCTCCCAGATCACA-TAMRA
IL-21 Forward 5-TGTGAATGACTTGGTCCCTGAA-3
Reverse 5-AACAGGAAAAAGCTGACCACTCA-3
Probe FAM-TCTGCCAGCTCCAGAAGATGTAGAGACAAAC-TAMRA
IL-23 Forward 5-TCAGTGCCAGCAGCTTTCAC-3
Reverse 5-TCTCTTAGATCCATGTGTCCCAC-3
Probe FAM-CTCTGCACACTGGCCTGGAGTGCA-TAMRA
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cytokines in the gastric mucosa of 7 patients with poly-
morphisms IL23R C/C, 10 patients with A/C and 17 pa-
tients with A/A (wild type). As shown in Fig. 4, the ex-
pression of IL-6 (p = 0.422), IL-17 (p = 0.120), IL-21 
(p = 0.646), IL-23 (p = 0.093) and TGF-β1 (p = 0.483) 
were not significant higher in patients with SNPs in IL- 
IL23R +2199A/C gene.
Discussion
The correlation of genetic host factors in gastroduode-
nal diseases associated with H. pylori infection has been 
demonstrated in previous reports with genes participat-
ing in inflammation (36-38). Regulation of the immune 
response seems to be critical in determining the severity 
of damage to the host (38-40). In this study, we suspect 
infected. Since polymorphisms in IL-17F may affect its 
function, we studied the expression of inflammation-re-
lated cytokines in the gastric mucosa of 10 patients with 
polymorphisms IL-17F A/G and 25 patients with A/A 
(wild type). As shown in Fig. 3, the expression of IL-6 
(p = 0.826), IL-17 (p = 0.378), IL-21 (p = 0.434), IL-23 
(p = 0.534) and TGF-β1 (p = 0.194) was not significant 
higher in patients with SNPs in IL-17A gene.
Expression of IL-6, IL-21, IL-23, IL-17 and TGF-β1 
in biopsies of H. pylori-infected with SNPs in IL23R 
+2199A/C gene 
IL-6, IL-21, IL-23, IL-17 and TGF-β1 mRNAs were 
detectable in all biopsies was taken from H. pylori-infect-
ed. Since polymorphisms in IL23R may affect its func-
tion, we studied the expression of inflammation-related 
Fig. 2. — Expression of cytokines in biopsies of H. pylori infected patients with SNPs in IL-17A gene and patients with the wild type 
IL-17A gene. Quantitative PCR was performed to estimate the relative expression levels of each cytokine. Expression of IL-6 (A), 
IL-17(B), IL-21 (C), IL-23 (D) and TGF-β1 (E) were normalized with expression values of human β-actin. Difference in mRNAs 
expression between patients with SNPs in IL-17A G197A were not significant in H. pylori-infected patients. P value < 0.05 was 
considered statistically significant using the Kruskal-Wallis test.
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chemokines as well as powerful inhibitor of gastric acid 
secretion IL-1β (43, 44) which potentiate tumor growth 
in noncardia site. Xiaoqin et al. suggested that IL-17F 
might promote tumor progression by facilitating tumor 
proliferation and invasion into neighboring tissues and 
lymph node and the IL-17A 197 polymorphism is associ-
ated with increased risk of certain subtypes of gastric 
cancer, but not with total gastric cancer risk (33).  Horvath 
et al. studies indicate that IL-23 makes a contribution to 
both Th1 and Th17 responses during H. pylori infection 
particularly during the chronic stage of infection (45). 
Another study indicated that polymorphisms of IL23R 
gene were associated with gastric cancer in a low risk 
Chinese population and they found that the IL23R 
+2199CC genotype significantly decreased gastric can-
cer risk (34). Together with their previous result that IL-
17F 7488GG genotype markedly elevated the risk of gas-
tric cancer. The possible explanation for their result is, by 
modifying transcription factor binding sites or affecting 
the structure of messenger RNA (mRNA), the IL23R 
that IL-17A, IL-17F and IL23R genotypes confers an in-
creased risk for development of gastritis and the rapid 
progression of gastric mucosal atrophy via affect the ex-
pression of cytokines such as IL-6, IL-21, IL-23, IL-17A 
and TGF-β1 in chronic gastritis stage. We found that IL-
17A, IL-17F and IL23R genotypes were not related to 
mucosal expression of IL-6, IL-21, IL-23, IL-17A and 
TGF-β1 mRNAs in H. pylori-infected patients. These 
findings suggest that IL-17A, IL-17F and IL23R poly-
morphisms have no effect on mucosal expression of IL-6, 
IL-21, IL-23, IL-17A and TGF-β1 mRNAs involved in 
IL-23/IL-17 axis. Recent studies have suggested that IL-
17 plays a main role in the inflammatory response to the 
H. pylori infection and finally influences the outcome of 
the H. pylori-related diseases and regulates immunity to-
wards this bacterium (28, 29, 41). Arisawa et al. reported 
that IL-17F 7488 polymorphism was reported to interact 
with H. pylori infection to increase the inflammation and 
activity scores (42). It is well known that IL-17F can in-
duce a diverse set of pro-inflammatory cytokines and 
Fig. 3. — Expression of cytokines in biopsies of H. pylori infected patients with SNPs in IL-17F gene and patients with the wild type 
IL-17F gene. Quantitative PCR was performed to estimate the relative expression levels of each cytokine. Expression of IL-6 (A), 
IL-17(B), IL-21 (C), IL-23 (D) and TGF-β1 (E) were normalized with expression values of human β-actin. Difference in mRNAs 
expression between patients with SNPs in IL-17F A7488G were not significant in H. pylori-infected patients. P value < 0.05 was 
considered statistically significant using the Mann-Whitney test.
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environment by dominating innate and inflammatory 
cells which is associated with inflammatory correlated 
carcinoma. By contrast, this IL-23/IL-17 pathway might 
also purpose tumor immune surveillance of elimination, 
equilibrium and escape (46). The former role could par-
tially involve in the pathogenesis gastric cancer, while 
ovary cancer prone to be associated with the later mecha-
nism. However, our study suggests that these polymor-
phisms may alter mucosal cytokine pattern by regulating 
IL-6, IL-21, IL-23, IL-17A and TGF-β1 production and, 
probably, the consequent release of these cytokines, 
causes the development of severe histological changes in 
the gastric mucosa patients with gastritis. Our results 
highlighted the role of H. pylori and mucosal expression 
+2199A/C polymorphism located in 3-UTR might lower 
the level of IL-23R expression and modulate the function 
of IL-23/IL-17 inflammatory axis, which was reported to 
get actively involved in the chronic gastritis step of intes-
tinal type of gastric cancer formation (28). IL23R is an 
important modulator in the inflammatory process. And 
patients with precancerous lesions in younger age are 
more likely to have early stages lesions and may have 
stronger immunity to prevent against the carcinogenic 
agents. Therefore, the inverse association based on the 
immunity activation is easier to be implemented in 
younger population. According to the previous litera-
ture ; IL-23/IL-17 axis has two different roles in tumori-
genesis. On one hand, it promotes a pro-inflammatory 
Fig. 4. — Expression of cytokines in biopsies of H. pylori infected patients with SNPs in IL23R gene and patients with the wild type 
IL23R gene. Quantitative PCR was performed to estimate the relative expression levels of each cytokine. Expression of IL-6 (A), 
IL-17(B), IL-21 (C), IL-23 (D) and TGF-β1 (E) were normalized with expression values of human β-actin. Difference in mRNAs 
expression between patients with SNPs in IL23R +2199A/C were not significant in H. pylori-infected patients. P value < 0.05 was 
considered statistically significant using the Kruskal-Wallis test.
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patients rather polymorphism because many studies do 
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studies are needed to analyze these polymorphisms with 
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